Madeleine Eunice Betouke Ongwe

Dr. Madeleine Eunice Betouke Ongwe

Parasitology, Leiden University Medical Center, Leiden, The Netherlands
+1
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 April 2021 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
SJSanne E. de Jong
Sanne E. de Jong
VUVincent van Unen
Vincent van Unen
MMMikhael D. Manurung
Mikhael D. Manurung
KSKoen A. Stam
Koen A. Stam
JGJelle J. Goeman
Jelle J. Goeman
MYMaria Yazdanbakhsh
Maria Yazdanbakhsh

1 October 2021 in PLOS Neglected Tropical Diseases
Verified
Journal Article
Open access
PDF file
YMYoanne D. Mouwenda
Yoanne D. Mouwenda
Madeleine Eunice Betouke OngweMadeleine Eunice Betouke Ongwe
Madeleine Eunice Betouke Ongwe
FSFriederike Sonnet
Friederike Sonnet
KSKoen A. Stam
Koen A. Stam
LLLucja A. Labuda
Lucja A. Labuda
MYMaria Yazdanbakhsh
Maria Yazdanbakhsh
Two hookworm vaccine candidates, Na-GST-1 and Na-APR-1, formulated with Glucopyranosyl Lipid A (GLA-AF) adjuvant, have been shown to be safe, well tolerated, and to induce antibody responses in a Phase 1 clinical trial (Clinicaltrials.gov NCT02126462) conducted in Gabon. Here, we characterized T cell responses in 24 Gabonese volunteers randomized to get vaccinated three times with Na-GST-1 and Na-APR-1 at doses of 30μg (n = 8) or 100μg (n = 10) and as control Hepatitis B (n = 6). Blood was collected pre- and post-vaccination on days 0, 28, and 180 as well as 2-weeks after each vaccine dose on days 14, 42, and 194 for PBMCs isolation. PBMCs were stimulated with recombinant Na-GST-1 or Na-APR-1, before (days 0, 28 and 180) and two weeks after (days 14, 42 and 194) each vaccination and used to characterize T cell responses by flow and mass cytometry. A significant increase in Na-GST-1 -specific CD4+ T cells producing IL-2 and TNF, correlated with specific IgG antibody levels, after the third vaccination (day 194) was observed. In contrast, no increase in Na-APR-1 specific T cell responses were induced by the vaccine. Mass cytometry revealed that, Na-GST-1 cytokine producing CD4+ T cells were CD161+ memory cells expressing CTLA-4 and CD40-L. Blocking CTLA-4 enhanced the cytokine response to Na-GST-1. In Gabonese volunteers, hookworm vaccine candidate, Na-GST-1, induces detectable CD4+ T cell responses that correlate with specific antibody levels. As these CD4+ T cells express CTLA-4, and blocking this inhibitory molecules resulted in enhanced cytokine production, the question arises whether this pathway can be targeted to enhance vaccine immunogenicity.

6 December 2022 in Metabolites
Verified
Journal Article
Open access
PDF file
Madeleine Eunice Betouke OngweMadeleine Eunice Betouke Ongwe
Madeleine Eunice Betouke Ongwe
IKIsabelle Kohler
Isabelle Kohler
MMMikhael D. Manurung
Mikhael D. Manurung
AVAswin Verhoeven
Aswin Verhoeven
RDRico Derks
Rico Derks
MYMaria Yazdanbakhsh
Maria Yazdanbakhsh
The interaction of malaria parasites with their human host is extensively studied, yet only few studies reported how P. falciparum infection affects urinary metabolite profiles and how this is associated with immunity. We present a longitudinal study of the urinary metabolic profiles of twenty healthy Africans with lifelong exposure to malaria and five malaria-naïve Europeans, who were all challenged with direct venous inoculation of live P. falciparum sporozoïtes (PfSPZ) and followed up until they developed symptoms or became thick blood smear positive (TBS). Urine samples were collected before and at 2, 5, 9 and 11 days post challenge and were analysed. Upon infection, all Europeans became TBS positive, while Africans showed either a delay in time to parasitaemia or controlled infection. Our metabolic data showed that Europeans and Africans had distinct alterations in metabolite patterns, with changes mostly seen on days 5 and 9 post PfSPZ infection, and more prominently in Europeans. Within the African group, the levels of formate, urea, trimethylamine, threonine, choline, myo-inositol and acetate were significantly higher in TBS positive whereas the levels of pyruvate, 3-methylhistidine and dimethylglycine were significantly lower in individuals who remained TBS negative. Notably, before inoculation with PfSPZ, a group of metabolites including phenylacetylglutamine can potentially be used to predict parasitaemia control among Africans. Taken together, this study highlights the difference in urinary metabolic changes in response to malaria infection as a consequence of lifelong exposure to malaria and that change detectable before challenge might predict the control of parasitaemia in malaria-endemic areas.

12 December 2024 in Sensors
Verified
Journal Article
Open access
PDF file
JJJuul-Kristensen Juul-Kristensen
Juul-Kristensen Juul-Kristensen
CTCeline Thiesen
Celine Thiesen
LHLine Wulff Haurum
Line Wulff Haurum
JKJosephine Keller
Josephine Keller
RLRoméo Wenceslas Lendamba
Roméo Wenceslas Lendamba
CTCinzia Tesauro
Cinzia Tesauro
Malaria poses a serious global health problem, with half the world population being at risk. Regular screening is crucial for breaking the transmission cycle and combatting the disease spreading. However, current diagnostic tools relying on blood samples face challenges in many malaria-epidemic areas. In the present study, we demonstrate the detection of the malaria-causing Plasmodium parasite in non-invasive saliva samples (N = 61) from infected individuals by combining a DNA-based Rolling-circle-Enhanced-Enzyme-Activity-Detection (REEAD) sensor system with a chemiluminescence readout that could be detected with an in-house-developed affordable and battery-powered portable reader. We successfully transferred the technology to sub-Saharan Africa, where the malaria burden is high, and demonstrated a proof of concept in a small study (N = 40) showing significant differences (p < 0.00001) between malaria-positive individuals (N = 33) and presumed asymptomatic negative individuals (N = 7) all collected in Gabon. This is the first successful application of the REEAD sensor system for the detection of malaria in saliva in a high-epidemic area and holds promise for the potential future use of REEAD for malaria diagnosis or surveillance based on non-invasive specimens in sub-Saharan Africa.

14 June 2024 in European Journal of Immunology
Verified
Journal Article
Open access
Madeleine Eunice Betouke OngweMadeleine Eunice Betouke Ongwe
Madeleine Eunice Betouke Ongwe
YMYoanne D. Mouwenda
Yoanne D. Mouwenda
MMMikhael D. Manurung
Mikhael D. Manurung
GHGraham Heieis
Graham Heieis
SAShohreh Azimi
Shohreh Azimi
BEBart Everts
Bart Everts
Cellular metabolism is a key determinant of immune cell function. Here we found that CD14+ monocytes from Sub‐Saharan Africans produce higher levels of IL‐10 following TLR‐4 stimulation and are bioenergetically distinct from monocytes from Europeans. Through metabolomic profiling, we identified the higher IL‐10 production to be driven by increased baseline production of NADPH oxidase‐dependent reactive oxygen species, supported by enhanced pentose phosphate pathway activity. Together, these data indicate that NADPH oxidase‐derived ROS is a metabolic checkpoint in monocytes that governs their inflammatory profile and uncovers a metabolic basis for immunological differences across geographically distinct populations.

26 September 2022 in PLOS ONE
Verified
Journal Article
Open access
PDF file
Madeleine Eunice Betouke OngweMadeleine Eunice Betouke Ongwe
Madeleine Eunice Betouke Ongwe
YMYoanne D. Mouwenda
Yoanne D. Mouwenda
KSKoen A. Stam
Koen A. Stam
PKPeter G. Kremsner
Peter G. Kremsner
BLBertrand Lell
Bertrand Lell
MYMaria Yazdanbakhsh
Maria Yazdanbakhsh
Metabolomics provides a powerful tool to study physiological changes in response to various perturbations such as vaccination. We explored whether metabolomic changes could be seen after vaccination in a phase I trial where Gabonese adults living either in rural or semi-urban areas received the subunit hookworm vaccine candidates (Na-GST-1 and Na-APR-1 (M74) adjuvanted with Alhydrogel plus GLA-AF (n = 24) or the hepatitis B vaccine (n = 8) as control. Urine samples were collected and assayed using targeted 1H NMR spectroscopy. At baseline, a set of metabolites significantly distinguished rural from semi-urban individuals. The pre- and post-vaccination comparisons indicated significant changes in few metabolites but only one day after the first vaccination. There was no relationship with immunogenicity. In conclusion, in a small phase 1 trial, urinary metabolomics could distinguish volunteers with different environmental exposures and reflected the safety of the vaccines but did not show a relationship to immunogenicity.